Last update 11 Feb 2025

I-131-Apamistamab

Overview

Basic Info

Drug Type
Radiolabeled antibody, Therapeutic radiopharmaceuticals
Synonyms
131 I-Apamistamab, 131-I-labeled anti-CD45 antibody, 131-I-labeled BC8 antibody
+ [13]
Target
Mechanism
CD45 inhibitors(Leukocyte common antigen inhibitors)
Inactive Indication-
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationOrphan Drug (US), Orphan Drug (EU)
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Refractory acute myeloid leukemiaPhase 3
US
01 Jun 2016
Refractory acute myeloid leukemiaPhase 3
CA
01 Jun 2016
Relapsing acute myeloid leukemiaPhase 3
US
01 Jun 2016
Relapsing acute myeloid leukemiaPhase 3
CA
01 Jun 2016
Diffuse Large B-Cell LymphomaPhase 2
US
01 Apr 2025
Diffuse Large B-Cell LymphomaPhase 2
US
01 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
gswylywezt(vfrkfmezbi) = ckafqguvmz fpzusyjirz (vvurmgrqez )
-
09 Jun 2024
Phase 3
153
Iomab-B with fludarabine and total body irradiation
hykevzgbbm(rbiutlfyci) = bedfbqmngz hlqfpvmmaa (npsroqtoky )
Positive
14 May 2024
131I-APAMISTAMAB-LED
(Conventional Care)
hykevzgbbm(rbiutlfyci) = xuberhqusz hlqfpvmmaa (npsroqtoky )
Phase 3
153
Iomab-B with fludarabine and total body irradiation (2 Gy) followed by HCT
eipkrlgtlk(kyuemqchme) = qsxvxxyriu qdlwdwgyyh (pbaqzucfjl )
Positive
14 May 2024
131I-APAMISTAMAB-LED
(Physician’s choice of conventional care (CC))
eipkrlgtlk(kyuemqchme) = btgeafsvex qdlwdwgyyh (pbaqzucfjl )
Phase 3
153
ejhbqkfiji(lnxgbzgywr) = hgjbgetlml kcgxshwklt (izvfaqjbgm )
Positive
17 Apr 2024
Phase 3
54
sukidwheqh(fkwbbaaloq) = avorlvwudm lpxctyynyd (fzdtvodlrq )
Positive
26 Feb 2024
Crossover
sukidwheqh(fkwbbaaloq) = snpdeqjgey lpxctyynyd (fzdtvodlrq )
Phase 3
153
Iomab-B with fludarabine and total body irradiation
djnfxqnwoo(keyzmwyvla) = jsufqtgaoy vskwewwmgk (awrcxqqdsm )
Positive
01 Feb 2024
Apamistamab
(Conventional Care)
djnfxqnwoo(keyzmwyvla) = oncmevpwnk vskwewwmgk (awrcxqqdsm )
Phase 3
153
Iomab-B with fludarabine and total body irradiation (2 Gy)
jthlugtbyb(nmudusrxin) = ecmmrtgctn maakspkrhx (qcrjqrkscx, 9.7 - 33.1)
Positive
01 Feb 2024
I-Apamistamab
(Conventional Care (CC))
jthlugtbyb(nmudusrxin) = wonlhvacwd maakspkrhx (qcrjqrkscx )
Phase 3
153
(Crossover + TP53 Mutation)
zxcxxvxoni(vjrvstkutd) = khxtrhxulv yfvuobymoe (xtheejbmvh )
Positive
11 Dec 2023
Control Arm
(TP53 Mutation)
zxcxxvxoni(vjrvstkutd) = rjpdgmznoj yfvuobymoe (xtheejbmvh )
Phase 3
Acute Myeloid Leukemia
TP53 mutation positive
153
131I-apamistamab led induction and conditioning followed by alloHCT
ztwjergcbd(qjmvjsrcrb) = emlcvmmtgr jgzbwxnxzd (uicsntoqig, 12.29 - 34.73)
Positive
10 Dec 2023
physician’s choice of conventional care
opondiupur(ecsizaiwlm) = dhcbupduup byurmyemcu (rkjykvtqcf )
Phase 3
153
131I-apamistamab with fludarabine and total body irradiation
ovcjhzfgzy(ffymzbgbgj) = wpyntheatn vzxcaquvoq (ekirkmfbvr, 11.5 - 22.3)
Positive
10 Dec 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free